PROPOXYPHENE COMPOUND 65 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propoxyphene Compound 65, and when can generic versions of Propoxyphene Compound 65 launch?
Propoxyphene Compound 65 is a drug marketed by Ivax Sub Teva Pharms, Sandoz, and Teva. and is included in three NDAs.
The generic ingredient in PROPOXYPHENE COMPOUND 65 is aspirin; caffeine; propoxyphene hydrochloride. There is one drug master file entry for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROPOXYPHENE COMPOUND 65?
- What are the global sales for PROPOXYPHENE COMPOUND 65?
- What is Average Wholesale Price for PROPOXYPHENE COMPOUND 65?
Summary for PROPOXYPHENE COMPOUND 65
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Patent Applications: | 4,371 |
| DailyMed Link: | PROPOXYPHENE COMPOUND 65 at DailyMed |
US Patents and Regulatory Information for PROPOXYPHENE COMPOUND 65
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Sub Teva Pharms | PROPOXYPHENE COMPOUND 65 | aspirin; caffeine; propoxyphene hydrochloride | CAPSULE;ORAL | 083077-002 | Dec 7, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | PROPOXYPHENE COMPOUND 65 | aspirin; caffeine; propoxyphene hydrochloride | CAPSULE;ORAL | 080044-002 | Sep 16, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | PROPOXYPHENE COMPOUND 65 | aspirin; caffeine; propoxyphene hydrochloride | CAPSULE;ORAL | 089025-001 | Mar 29, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
